Delivery Order 36F79720D0099-36C24525N0901
Award Date
8/13/25
Potential Completion Date
8/19/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 5
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The contract, valued at $12,559.90, is for the delivery of the drug JYNARQUE (tolvaptan) in 90mg-30mg dosages. JYNARQUE is used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract is a Delivery Order under Otsuka's existing Federal Supply Schedule (FSS) contract with the VA, which has a...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The award, valued at $12,559.90, is for the delivery of the drug Jynarque (tolvaptan) in 90mg/30mg dosage to VA medical facilities and integrated service networks. Jynarque is used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract is a Delivery Order issued under Otsuka's existing...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The contract is a Delivery Order against Otsuka's $396 million Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, which allows the VA to procure a range of Otsuka's commercial drug offerings. The primary product being delivered under this $12,580.72 firm-fixed price contract is Jynarque (tolvaptan), a...
This federal contract award to Otsuka America Pharmaceutical Inc. is a Delivery Order with a ceiling value of $362,719.21. The contract is issued under a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for Pharmaceuticals and Drugs (FSS-61-IB). The award is for the drug Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease and hyponatremia. Otsuka America Pharmaceutical is a for-profit pharmaceutical manufacturer that...
The Department of Veterans Affairs (VA) awarded a sole-source delivery order to Otsuka America Pharmaceutical Inc. for the supply of Jynarque (tolvaptan), a medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The order, valued at $132,073.87, is a firm-fixed-price contract issued under Otsuka's $396 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This contract, along with a $15 million Blanket Purchase Agreement...
This federal contract award was issued by the Veterans Integrated Service Network 1 (VISN 1), part of the U.S. Department of Veterans Affairs (VA), to Otsuka America Pharmaceutical Inc. The $123,851.92 delivery order is for the supply of Jynarque (tolvaptan), a medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. Otsuka America Pharmaceutical is a for-profit pharmaceutical manufacturer and supplier that provides prescription drugs and specialty medications to...
This federal contract award to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, is for the delivery of the drug Jynarque (tolvaptan) to the U.S. Department of Veterans Affairs (VA). The contract, valued at $12,580.72, is a delivery order issued under two larger Indefinite Delivery Vehicles (IDVs) held by Otsuka with the VA: a $15 million Blanket Purchase Agreement (BPA) and a $396 million Federal Supply Schedule (FSS) contract, both awarded in March 2020 and set to...
This federal contract award was made by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The contract is for the delivery of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract is a Blanket Purchase Agreement (BPA) with a ceiling value of $113,303.91 and a period of performance from October 2020 to October 2021. It was awarded...
This federal contract award is for the drug JYNARQUE, which is used to treat autosomal dominant polycystic kidney disease and hyponatremia. The $100,645.76 firm-fixed price delivery order was awarded to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of March 25, 2024. Otsuka holds two significant...
This federal contract award to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) for the delivery of the prescription drug Jynarque (tolvaptan). The contract is a delivery order valued at $12,559.90 and has a completion date of November 13, 2024. Jynarque is used to treat autosomal dominant polycystic kidney disease and hyponatremia. Otsuka America Pharmaceutical holds two Indefinite Delivery Vehicles (IDVs)...